Department of Physical Therapy, Rehabilitation Science, and Athletic Training, University of Kansas Medical Center, Kansas City, Kansas, USA,
University of Kansas Alzheimer's Disease Research Center, University of Kansas Medical Center, Kansas City, Kansas, USA.
Gerontology. 2023;69(11):1307-1314. doi: 10.1159/000531263. Epub 2023 Aug 9.
Older adults with preclinical Alzheimer's disease (AD) show changes in on-road driving performance. The impact of preclinical AD on using automated vehicle (AV) technology is unknown. The aim was to evaluate safety and cognitive workload while operating AV technology in drivers with preclinical AD.
This cross-sectional study included 40 participants: 19 older adults (age 74.16 ± 4.78; MOCA scores 26.42 ± 2.52) with preclinical AD, evidenced by elevated cortical beta-amyloid; and 21 controls (age 73.81 ± 5.62; MOCA scores 28.24 ± 1.67). All participants completed two scenarios in a driving simulator. Scenario 1 included conditional automation with an emergency event that required a manual take-over maneuver. Scenario 2 was identical but with a cognitive distractor task. Emergency response time was the main safety outcome measure. Cognitive workload was calculated using moment-to-moment changes in pupillary size and converted into an Index of Cognitive Activity (ICA). Mann-Whitney U and independent t tests were used to compare group differences.
Emergency response times were similar between drivers with preclinical AD and controls in scenario 1 (20.85 s ± 1.08 vs. 20.52 s ± 3.18; p = 0.83) and scenario 2 (14.83 s ± 7.37 vs. 13.45 s ± 10.43; p = 0.92). Likewise, no differences were found in ICA between drivers with preclinical AD and controls in scenario 1 (0.34 ± 0.08 vs. 0.33 ± 0.17; p = 0.74) or scenario 2 (0.30 ± 0.07 vs. 0.29 ± 0.17; p = 0.93).
Older drivers with preclinical AD may safely operate AV technology, without increased response times or cognitive workload. Future on-road studies with AV technology should confirm these preliminary results in drivers with preclinical AD.
患有临床前阿尔茨海默病(AD)的老年人在道路驾驶表现上出现变化。临床前 AD 对使用自动化车辆(AV)技术的影响尚不清楚。本研究旨在评估患有临床前 AD 的驾驶员在操作 AV 技术时的安全性和认知工作量。
这项横断面研究纳入了 40 名参与者:19 名年龄为 74.16±4.78 岁(蒙特利尔认知评估量表[MOCA]评分为 26.42±2.52)的老年人患有临床前 AD,其大脑皮质β-淀粉样蛋白升高;21 名对照组参与者年龄为 73.81±5.62 岁(MOCA 评分为 28.24±1.67)。所有参与者均在驾驶模拟器中完成了两个场景。场景 1 包括有条件的自动化和需要手动接管的紧急事件。场景 2 与之相同,但增加了认知干扰任务。紧急响应时间是主要的安全结果测量指标。使用瞳孔大小的即时变化计算认知工作量,并转换为认知活动指数(ICA)。采用曼-惠特尼 U 检验和独立 t 检验比较组间差异。
在场景 1(20.85±1.08 秒对 20.52±3.18 秒;p=0.83)和场景 2(14.83±7.37 秒对 13.45±10.43 秒;p=0.92)中,患有临床前 AD 的驾驶员与对照组的紧急响应时间相似。同样,在场景 1(0.34±0.08 对 0.33±0.17;p=0.74)或场景 2(0.30±0.07 对 0.29±0.17;p=0.93)中,患有临床前 AD 的驾驶员与对照组之间的 ICA 也没有差异。
患有临床前 AD 的老年驾驶员可能安全地操作 AV 技术,而不会增加响应时间或认知工作量。未来应使用 AV 技术进行的道路研究来确认这些初步结果。